Alnylam Pharmaceuticals, Inc.
- Home
- Companies & Suppliers
- Alnylam Pharmaceuticals, Inc.
- Downloads
- OXLUMO lumasiran Brochure
OXLUMO lumasiran Brochure
The first and only FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.